For example, in triple damaging breast cancer (TNBC),25 As well as in hepatocellular carcinoma,26 DNA methylation profiles have helped towards the identification of distinctive subgroups with clinical relevance. Epigenetic ways have also assisted to the event of prognostic checks to assess the sensitivity of cancer cells to certain medicine.27 https://directivepublications.org/world-journal-of-clinical-cancer-research/